Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Endometrial Neoplasms 20Anorexia 11Cachexia 9Neoplasms 8Breast Neoplasms 8Endometrial Hyperplasia 7Weight Loss 3Recurrence 2Overweight 2Obesity 2Lung Neoplasms 2Head and Neck Neoplasms 2Body Weight Changes 2Body Weight 2Vomiting 1Turcot syndrome 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Prosthesis Failure 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Nutrition Disorders 1Neoplasms, Second Primary 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Menorrhagia 1

Interventions

Temozolomide 2Radiosurgery 2Leucovorin 2Irinotecan 2Fluorouracil 2sacubitril and valsartan sodium hydrate drug combination 1icotinib 1dostarlimab 1beta Carotene 1avelumab 1alpha-Tocopherol 1Varenicline 1Tobacco Use Cessation Devices 1Therapeutics 1Thalidomide 1Radiotherapy 1Probiotics 1Panitumumab 1Nicotine Chewing Gum 1Myofascial Release Therapy 1Megestrol Acetate 1Isotretinoin 1Folfox protocol 1Drug Therapy 1Doxycycline 1Docetaxel 1Cryosurgery 1Clonidine 1Cetuximab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Second Primary × Megestrol Acetate × Clear all
NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown
200 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡